AI Biotech, BioXcel Therapeutics, Files for $69M IPO
The Branford, CT-based company was founded in 2017 and plans to list on the Nasdaq under the symbol BTAI. Source: BioSpace
The Branford, CT-based company was founded in 2017 and plans to list on the Nasdaq under the symbol BTAI. Source: BioSpace
That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace
AmerisourceBergen is one of the biggest drug distributors in the U.S. Source: BioSpace
A look at a few bargains in today's choppy market. Source: BioSpace
Amicus announced that the FDA accepted its NDA for migalastat to treat Fabry disease in patients with amenable mutations. Source: BioSpace
With the deal in hand, Roivant has stepped into the world of metabolic diseases. Source: BioSpace
The fast-growing company will anchor 399 Binney St., an Alexandria Real Estate Equities property. Source: BioSpace
Mr. Goater succeeds interim chief executive officer Dan Lynch, who will remain executive chairman of Surface’s board of directors. Source: BioSpace
The study assessed two doses of RG7716 versus ranibizumab standard of care given as monthly intravitreal injections. Source: BioSpace
Axovant shares plunged after Hung abruptly resigned as CEO and also stepped down from his seat on the company board of directors. Source: BioSpace